# Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin

> **NCT01335529** · PHASE2 · COMPLETED · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 69 (actual)

## Conditions studied

- HCV Coinfection
- HIV-1 Infection

## Interventions

- **DRUG:** Boceprevir, Peg-interferon alfa 2b and Ribavirin

## Key facts

- **NCT ID:** NCT01335529
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2014-10-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01335529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01335529, "Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01335529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*